tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 1118 are a BUY (92.93%), 81 are a HOLD (6.73%), 4 are a SELL (0.33%).
Analyst Raghuram Selvaraju, carries an average stock price target met ratio of 35.18% that have a potential upside of 50.98% achieved within 199 days. Previously, Raghuram Selvaraju worked at HC WAINWRIGHT.
Raghuram Selvaraju’s has documented 2,189 price targets and ratings displayed on 129 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on PLX, Protalix Biotherapeutics at 21-Nov-2025.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for EVOK (EVOKE PHARMA) at 7/18/2016. The price target of $288 was fulfilled within 3 days with a profit of $128.16 (30.8%) receiving and performance score of 102.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$12
$-4.38 (-26.74%)
$7
5 months 2 days ago
(24-Jun-2025)
8/13 (61.54%)
$-4.19 (-25.88%)
55
Buy
1 years 5 months 9 days ago
(17-Jun-2024)
10/37 (27.03%)
$101 (102.02%)
298
Sell
2 years 7 days ago
(19-Nov-2023)
1/3 (33.33%)
$-0.8 (-0.99%)
300
Hold
$20
$3.62 (22.10%)
$60
2 years 1 months 2 days ago
(24-Oct-2023)
3/22 (13.64%)
$5.72 (40.06%)
40
Hold
$25
$8.62 (52.63%)
$40
2 years 4 months 8 days ago
(18-Jul-2023)
2/5 (40%)
$3.4 (15.74%)
215
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
